Heron Therapeutics, Inc. (HRTX)
0.4061
+0.05
(+13.37%)
USD |
NASDAQ |
Oct 09, 16:00
0.4049
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Free Cash Flow : -12.14M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.14M |
| March 31, 2026 | -20.86M |
| December 31, 2025 | -27.91M |
| September 30, 2025 | -31.14M |
| June 30, 2025 | -29.53M |
| March 31, 2025 | -23.70M |
| December 31, 2024 | -24.24M |
| September 30, 2024 | -9.612M |
| June 30, 2024 | -22.52M |
| March 31, 2024 | -44.73M |
| December 31, 2023 | -60.33M |
| September 30, 2023 | -100.49M |
| June 30, 2023 | -127.63M |
| March 31, 2023 | -128.88M |
| December 31, 2022 | -148.74M |
| September 30, 2022 | -156.44M |
| June 30, 2022 | -174.02M |
| March 31, 2022 | -208.64M |
| December 31, 2021 | -206.38M |
| September 30, 2021 | -215.78M |
| June 30, 2021 | -203.76M |
| March 31, 2021 | -198.48M |
| December 31, 2020 | -191.63M |
| September 30, 2020 | -167.46M |
| June 30, 2020 | -149.20M |
| Date | Value |
|---|---|
| March 31, 2020 | -116.45M |
| December 31, 2019 | -131.73M |
| September 30, 2019 | -137.82M |
| June 30, 2019 | -152.73M |
| March 31, 2019 | -189.52M |
| December 31, 2018 | -200.98M |
| September 30, 2018 | -212.30M |
| June 30, 2018 | -213.50M |
| March 31, 2018 | -183.95M |
| December 31, 2017 | -172.85M |
| September 30, 2017 | -163.78M |
| June 30, 2017 | -159.90M |
| March 31, 2017 | -155.57M |
| December 31, 2016 | -137.23M |
| September 30, 2016 | -121.48M |
| June 30, 2016 | -104.96M |
| March 31, 2016 | -92.80M |
| December 31, 2015 | -79.61M |
| September 30, 2015 | -70.04M |
| June 30, 2015 | -69.22M |
| March 31, 2015 | -65.95M |
| December 31, 2014 | -61.72M |
| September 30, 2014 | -57.64M |
| June 30, 2014 | -51.65M |
| March 31, 2014 | -49.82M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -160.40M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
| Alnylam Pharmaceuticals, Inc. | 793.94M |
| Anika Therapeutics, Inc. | 0.562M |
| Savara, Inc. | -110.66M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.213M |
| Cash from Investing (Quarterly) | -3.265M |
| Cash from Financing (Quarterly) | 0.082M |
| Free Cash Flow Per Share (Quarterly) | -0.0124 |
| Free Cash Flow to Equity (Quarterly) | -9.071M |
| Free Cash Flow to Firm (Quarterly) | -2.351M |
| Free Cash Flow Yield | -16.19% |